We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00004306
First Posted: October 19, 1999
Last Update Posted: March 6, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
The University of Texas Medical Branch, Galveston
Information provided by (Responsible Party):
Tetsuo Ashizawa, Office of Rare Diseases (ORD)
  Purpose

OBJECTIVES: I. Clinically evaluate members from families with a dominantly inherited ataxia and collect blood, skin and muscle samples for detailed molecular studies.

II. Perform detailed clinical evaluations on patients with recessively inherited ataxias.


Condition
Hereditary Ataxia

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Pathogenic Mechanism of Spinocerebellar Ataxia Type 10 (SCA10)

Resource links provided by NLM:


Further study details as provided by Tetsuo Ashizawa, Office of Rare Diseases (ORD):

Biospecimen Retention:   Samples With DNA
DNA from blood and skin and muscle biopsy samples.

Enrollment: 18
Study Start Date: November 1999
Study Completion Date: March 2009
Primary Completion Date: March 2009 (Final data collection date for primary outcome measure)
Detailed Description:

PROTOCOL OUTLINE: Participants undergo a comprehensive clinical and molecular evaluation. Studies include: neurologic evaluation, including magnetic resonance imaging and nerve conduction studies; ophthalmologic exam; audiologic exam, including auditory brain stem evoked response; DNA extraction from blood, skin and muscle; genotype phenotype correlation.

A neuropathologic evaluation is conducted postmortem, when possible.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   3 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with inherited ataxia
Criteria

Inclusion criteria:

Subjects who have the diagnosis of SCA10 and their immediate relatives.

Exclusion criteria:

Children under 3 years of age, pregnant women, prisoners, mentally incapacitated subjects, and subjects who do not give consent.

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00004306


Locations
United States, Texas
University of Texas Medical Branch at Galveston
Galveston, Texas, United States, 77555
Sponsors and Collaborators
Office of Rare Diseases (ORD)
The University of Texas Medical Branch, Galveston
Investigators
Principal Investigator: Tetsuo Ashizawa, MD University of Texas, Galveston
  More Information

Responsible Party: Tetsuo Ashizawa, Professor and Chair, Department of Neurology, The University of Texas Medical Branch, Office of Rare Diseases (ORD)
ClinicalTrials.gov Identifier: NCT00004306     History of Changes
Other Study ID Numbers: 199/11796
First Submitted: October 18, 1999
First Posted: October 19, 1999
Last Update Posted: March 6, 2012
Last Verified: March 2012

Keywords provided by Tetsuo Ashizawa, Office of Rare Diseases (ORD):
hereditary ataxia
neurologic and psychiatric disorders
rare disease

Additional relevant MeSH terms:
Ataxia
Cerebellar Ataxia
Spinocerebellar Ataxias
Spinocerebellar Degenerations
Dyskinesias
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Cerebellar Diseases
Brain Diseases
Central Nervous System Diseases
Spinal Cord Diseases
Heredodegenerative Disorders, Nervous System
Neurodegenerative Diseases
Genetic Diseases, Inborn